Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.42 - $0.68 $16,685 - $27,014
-39,727 Reduced 67.62%
19,020 $8,000
Q1 2023

May 15, 2023

SELL
$0.56 - $1.07 $20,544 - $39,255
-36,687 Reduced 38.44%
58,747 $37,000
Q4 2022

Feb 14, 2023

BUY
$0.58 - $17.99 $42,584 - $1.32 Million
73,422 Added 333.55%
95,434 $73,000
Q3 2022

Nov 14, 2022

SELL
$0.91 - $14.63 $93,833 - $1.51 Million
-103,114 Reduced 82.41%
22,012 $21,000
Q2 2022

Aug 15, 2022

BUY
$0.89 - $2.47 $41,967 - $116,472
47,155 Added 60.48%
125,126 $144,000
Q1 2022

May 16, 2022

SELL
$1.63 - $2.55 $351,897 - $550,514
-215,888 Reduced 73.47%
77,971 $187,000
Q4 2021

Feb 14, 2022

BUY
$2.27 - $3.0 $435,914 - $576,099
192,033 Added 188.59%
293,859 $711,000
Q3 2021

Nov 15, 2021

BUY
$2.45 - $4.1 $59,708 - $99,921
24,371 Added 31.46%
101,826 $311,000
Q2 2021

Aug 16, 2021

BUY
$3.0 - $4.39 $232,365 - $340,027
77,455 New
77,455 $301,000
Q1 2021

May 17, 2021

SELL
$2.2 - $5.05 $128,246 - $294,384
-58,294 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$1.85 - $2.54 $430,543 - $591,124
-232,726 Reduced 79.97%
58,294 $126,000
Q3 2020

Nov 16, 2020

SELL
$1.85 - $2.57 $38,439 - $53,399
-20,778 Reduced 6.66%
291,020 $588,000
Q2 2020

Aug 14, 2020

BUY
$1.59 - $2.51 $495,758 - $782,612
311,798 New
311,798 $633,000
Q4 2018

Feb 14, 2019

SELL
$5.95 - $14.49 $391,795 - $954,137
-65,848 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$7.51 - $14.21 $309,840 - $586,261
41,257 Added 167.77%
65,848 $936,000
Q2 2018

Aug 14, 2018

BUY
$9.01 - $13.33 $221,564 - $327,798
24,591 New
24,591 $242,000
Q1 2018

May 15, 2018

SELL
$9.38 - $12.12 $451,037 - $582,790
-48,085 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$9.15 - $18.9 $556,210 - $1.15 Million
-60,788 Reduced 55.83%
48,085 $466,000
Q3 2017

Nov 14, 2017

BUY
$11.55 - $21.79 $1.26 Million - $2.37 Million
108,873
108,873 $2.07 Million

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $105M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.